Antimetaboliskt antitumörmedel med immunsuppressiva egenskaper. De t interfererar med nukleinsyrasyntesen genom att hämma purinmetabolismen och används, vanligen i kombination med andra preparat, vid behandling av eller i remissionsunderhållsprogram för leukemi.
An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.
6-merkaptopurin — Purinethol — 6-tiopurin
6-Mercaptopurine — 6 Mercaptopurine — 6H-Purine-6-thione, 1,7-dihydro- — 6-Thiohypoxanthine — 6 Thiohypoxanthine — 6-Thiopurine — 6 Thiopurine — 1,7-Dihydro-6H-purine-6-thione — 6-Mercaptopurine Monohydrate — 6 Mercaptopurine Monohydrate — Purinethol — Puri-Nethol — Purimethol — Leupurin — BW 57-323H — BW 57323H — BW 57 323H — Mercaptopurina Wellcome — Mecaptopurine Anhydrous